Novo slumps, Lilly gains on trial data results
Investing.com -- Shares of Novo Nordisk (NYSE: NVO ) plummeted over 19% Friday after the results from its phase 3 trial of CagriSema, its next-generation obesity drug, disappointed. ...
Foxconn interest in Nissan on hold amid Honda merger talks, Bloomberg reports
(Reuters) -Taiwan's Foxconn (SS: 601138 ) is pausing its interest in Nissan (OTC: NSANY ) Motor as the Japanese automaker explores a potential merger wit...
Analysis-Trump's lawyers bring broad approach to court battles with media
By Jack Queen and Helen Coster (Reuters) - President-elect Donald Trump is adopting a wide-ranging legal strategy in suing media companies over what he describes as false or misleading cove...
